We are live on ! Find out more
FVF2

Flagship Ventures Fund 2007 Portfolio holdings

AUM $95.2M
This Fund
S&P 500
This Quarter Est. Return
-35.47%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.2M
AUM Growth
–
Cap. Flow
+$99.7M
Cap. Flow %
104.75%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$82.5M
2
MCRB icon
Seres Therapeutics
MCRB
+$15.6M
3
CARM
Carisma Therapeutics
CARM
+$1.32M
4
REGI
Renewable Energy Group, Inc.
REGI
+$258K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.67%
2 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
1
Agios Pharmaceuticals
AGIO
$1.99B
$78.4M 82.31%
+1,930,369
New +$82.5M
MCRB icon
2
Seres Therapeutics
MCRB
$51.3M
$15.9M 16.72%
+29,965
New +$15.6M
CARM
3
DELISTED
Carisma Therapeutics
CARM
$610K 0.64%
+95,350
New +$1.32M
REGI
4
DELISTED
Renewable Energy Group, Inc.
REGI
$317K 0.33%
+33,570
New +$258K

Similar funds

QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
SCM
SeaStone Capital Management New York $87.2M AUM 5.71% 1-Year Est. Return
WM
WCG Management New York $82.8M AUM 6.56% 1-Year Est. Return
PLCM
Plymouth Lane Capital Management New York $113M AUM 12.17% 1-Year Est. Return
STG
Symphony Technology Group Palo Alto, California $70.1M AUM
AC
Aternalis Capital New York $59.7M AUM
RCM
Reynolds Capital Management Las Vegas, Nevada $57.6M AUM 24.66% 1-Year Est. Return
IM
ISF Management New York $47.4M AUM 6.56% 1-Year Est. Return

Flagship Ventures Fund 2007's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Flagship Ventures Fund 2007, which disclosed 4 positions worth $95.2M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Agios Pharmaceuticals: 1,930,369 shares worth $78.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Materials.

  • Flagship Ventures Fund 2007's largest Q1 2016 buy was Agios Pharmaceuticals: 1,930,369 shares worth $78.4M.
  • Flagship Ventures Fund 2007's ten largest holdings make up 100% of its $95.2M portfolio in Q1 2016.
  • Flagship Ventures Fund 2007 disclosed 4 positions in Q1 2016, its first 13F filing on record.

Based on Flagship Ventures Fund 2007's 13F filing for Q1 2016, filed 13 May 2016.